-
EP3160503
Europäisches Verfahren
Auszug aus dem europäischen Patentregister
EP Übersicht: EP3160503
| EP3160503 - HEMMUNG DER SEROTONINEXPRESSION IN ENTEROENDOKRINEN DARMZELLENERGEBNISSEN BEI DER UMWANDLUNG IN INSULINPOSITIVE ZELLEN [Mit Rechtsklick auf diesen Link können Sie ein Bookmark anlegen.] | Status | Kein Einspruch fristgerecht eingelegt Status aktualisiert am 24.12.2021 Datenbank zuletzt aktualisiert am 04.11.2024 | |
| Frühere | Patent erteilt Status aktualisiert am 15.01.2021 | ||
| Frühere | Erteilung des Patents vorgesehen Status aktualisiert am 07.10.2020 | ||
| Frühere | Prüfungsverfahren läuft Status aktualisiert am 18.09.2020 | ||
| Frühere | Erteilung des Patents vorgesehen Status aktualisiert am 05.05.2020 | ||
| Frühere | Prüfungsverfahren läuft Status aktualisiert am 16.11.2018 | ||
| Frühere | Prüfungsantrag gestellt Status aktualisiert am 31.03.2017 | ||
| Frühere | Veröffentlichung bereits erfolgt Status aktualisiert am 27.01.2017 | Letztes Ereignis Tooltip | 06.09.2024 | Erlöschen des Patents in einem Vertragsstaat Neue Staaten: MT | veröffentlicht am 09.10.2024 [2024/41] | Anmelder | Für alle benannten Staaten The Trustees of Columbia University in the City of New York 412 Low Memorial Library 535 West 116th Street New York, NY 10027 / US | [2021/07] |
| Frühere [2017/18] | Für alle benannten Staaten The Trustees of Columbia University in the City of New York 412 Low Memorial Library 535 West 116th Street New York, New York 10027 / US | Erfinder | 01 /
ACCILI, Domenico 80 Chambers St. 15A New York, New York 10007 / US | 02 /
BOUCHI, Ryotaro National Center for Global Health and Medicine Department of Diabetes, Endoncrinology and Metabolism, Center Hospital Division of Clinical Information Research Diabetes and Metabolism Information Center Research Institute 1-21-1 Toyama, Shinjuku, Tokyo 162-8655 / JP | [2020/22] |
| Frühere [2017/28] | 01 /
ACCILI, Domenico 80 Chambers St. 15A New York, New York 10007 / US | ||
| 02 /
BOUCHI, Ryotaro National Center for Global Health and Medicine Department of Diabetes, Endoncrinology and Metabolism, Center Hospital Division of Clinical Information Research Diabetes and Metabolism Information Center Research Institute 1-21-1 Toyame, Shinjuku, Tokyo 162-8655 / JP | |||
| Frühere [2017/18] | 01 /
ACCILI, Domenico 80 Chambers St. 15A New York, New York 10007 / US | ||
| 02 /
BOUCHI, Ryotaro 2-19-12 Hyakunincho Shinjuku-ku Tokyo 169-0073 / JP | Vertreter | Chapman, Paul Gilmour, et al Marks & Clerk LLP 40 Torphichen Street Edinburgh EH3 8JB / GB | [2021/07] |
| Frühere [2017/18] | Chapman, Paul Gilmour Marks & Clerk LLP Atholl Exchange 6 Canning Street Edinburgh EH3 8EG / GB | Anmeldenummer, Anmeldetag | 15811242.5 | 26.06.2015 | [2017/18] | WO2015US38186 | Prioritätsnummer, Prioritätstag | US201462017405P | 26.06.2014 Ursprünglich veröffentlichtes Format: US 201462017405 P | [2017/18] | Anmeldesprache | EN | Verfahrenssprache | EN | Veröffentlichung | Art: | A1 Anmeldung mit Recherchenbericht | Nr.: | WO2015200901 | Datum: | 30.12.2015 | Sprache: | EN | [2015/52] | Art: | A1 Anmeldung mit Recherchenbericht | Nr.: | EP3160503 | Datum: | 03.05.2017 | Sprache: | EN | Die von der WIPO am 30.12.2015 in einer EPA-Amtssprache veröffentlichte Anmeldung tritt an die Stelle der Veröffentlichung der europäischen Patentanmeldung. | [2017/18] | Art: | B1 Patentschrift | Nr.: | EP3160503 | Datum: | 17.02.2021 | Sprache: | EN | [2021/07] | Recherchenbericht(e) | Internationaler Recherchenbericht - veröffentlicht am: | US | 30.12.2015 | (Ergänzender) europäischer Recherchenbericht - versandt am: | EP | 04.01.2018 | Klassifikation | IPC: | A61K31/7088, A61P3/10, C12N5/071, C12N15/113, A61K38/28 | [2020/13] | CPC: |
C12N15/113 (EP,US);
C12N5/0679 (US);
A61K31/7088 (EP);
A61K31/713 (EP);
A61K35/38 (US);
A61K38/28 (EP,US);
A61K45/06 (EP);
A61L27/3687 (US);
A61L27/3813 (US);
A61L27/383 (US);
A61L27/3882 (US);
A61P3/10 (EP);
C07K14/62 (US);
C07K16/40 (US);
C12N15/1137 (EP,US);
C12N5/0676 (EP);
C12Y114/16004 (EP,US);
C12Y401/01028 (EP,US);
A61L2430/22 (US);
C12N2310/11 (EP,US);
C12N2310/12 (EP,US);
C12N2310/14 (EP,US);
C12N2310/531 (EP,US);
C12N2501/60 (EP);
C12N2501/65 (EP);
C12N2501/825 (EP);
C12N2506/23 (US);
|
| Frühere IPC [2018/04] | A61K39/395, C12N15/113, A61P3/10, A61K38/28, A61L27/36 | ||
| Frühere IPC [2017/18] | A61K39/395, C12N15/113 | Benannte Vertragsstaaten | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/18] | Erstreckungsstaaten | BA | Noch nicht entrichtet | ME | Noch nicht entrichtet | Validierungsstaat(en) | MA | Noch nicht entrichtet | Bezeichnung der Erfindung | Deutsch: | HEMMUNG DER SEROTONINEXPRESSION IN ENTEROENDOKRINEN DARMZELLENERGEBNISSEN BEI DER UMWANDLUNG IN INSULINPOSITIVE ZELLEN | [2017/18] | Englisch: | INHIBITION OF SEROTONIN EXPRESSION IN GUT ENTEROENDOCRINE CELLS RESULTS IN CONVERSION TO INSULIN-POSITIVE CELLS | [2017/18] | Französisch: | L'INHIBITION DE L'EXPRESSION DE LA SÉROTONINE DANS DES CELLULES ENTÉROENDOCRINES INTESTINALES PROVOQUE LEUR CONVERSION EN CELLULES POSITIVES POUR L'INSULINE | [2017/18] | Eintritt in die regionale Phase | 26.01.2017 | Nationale Grundgebühr entrichtet | 26.01.2017 | Recherchengebühr entrichtet | 26.01.2017 | Benennungsgebühr(en) entrichtet | 26.01.2017 | Prüfungsgebühr entrichtet | Prüfungsverfahren | 26.01.2017 | Prüfungsantrag gestellt [2017/18] | 26.01.2017 | Datum, an dem die Prüfungsabteilung zuständig geworden ist | 02.08.2018 | Änderung durch den Anmelder (Ansprüche und/oder Beschreibung) | 15.11.2018 | Absendung einer Mitteilung der Prüfungsabteilung (Frist: M04) | 22.03.2019 | Erwiderung auf eine Mitteilung der Prüfungsabteilung | 02.05.2019 | Absendung einer Mitteilung der Prüfungsabteilung (Frist: M06) | 08.11.2019 | Erwiderung auf eine Mitteilung der Prüfungsabteilung | 06.05.2020 | Ankündigung der Patenterteilung | 15.09.2020 | Nichteinverständnis des Anmelders mit der Mitteilung über die beabsichtigte Erteilung eines Patents oder Wiederaufnahme des Prüfungsverfahrens durch das EPA | 15.09.2020 | Erteilungsgebühr entrichtet | 15.09.2020 | Veröffentlichungs-/Druckkostengebühr entrichtet | 08.10.2020 | Ankündigung der Patenterteilung | 07.01.2021 | Eingang der Übersetzungen des Patentanspruchs/der Patentansprüche | Einspruch (Einsprüche) | 18.11.2021 | Kein Einspruch fristgerecht eingelegt [2022/04] | Entrichtete Gebühren | Jahresgebühr | 16.06.2017 | Jahresgebühr entrichtet Patentjahr 03 | 25.06.2018 | Jahresgebühr entrichtet Patentjahr 04 | 28.06.2019 | Jahresgebühr entrichtet Patentjahr 05 | 15.06.2020 | Jahresgebühr entrichtet Patentjahr 06 |
| Ausschluss der ausschließlichen Tooltip Zuständigkeit des Einheitlichen Patentgerichts | Zu den entsprechenden Daten siehe das Register des Einheitlichen Patentgerichts | ||
| Die Verantwortung für die Richtigkeit, Vollständigkeit oder Qualität der unter dem Link angezeigten Daten liegt allein beim Einheitlichen Patentgericht. | Erlöschen während des Einspruchsverfahrens Tooltip | HU | 26.06.2015 | AL | 17.02.2021 | AT | 17.02.2021 | CY | 17.02.2021 | CZ | 17.02.2021 | DK | 17.02.2021 | EE | 17.02.2021 | ES | 17.02.2021 | FI | 17.02.2021 | HR | 17.02.2021 | IT | 17.02.2021 | LT | 17.02.2021 | LV | 17.02.2021 | MC | 17.02.2021 | MK | 17.02.2021 | MT | 17.02.2021 | NL | 17.02.2021 | PL | 17.02.2021 | RO | 17.02.2021 | RS | 17.02.2021 | SE | 17.02.2021 | SI | 17.02.2021 | SK | 17.02.2021 | SM | 17.02.2021 | BG | 17.05.2021 | NO | 17.05.2021 | GR | 18.05.2021 | IS | 17.06.2021 | PT | 17.06.2021 | IE | 26.06.2021 | LU | 26.06.2021 | BE | 30.06.2021 | CH | 30.06.2021 | LI | 30.06.2021 | [2024/41] |
| Frühere [2024/22] | HU | 26.06.2015 | |
| AL | 17.02.2021 | ||
| AT | 17.02.2021 | ||
| CY | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| MK | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| IE | 26.06.2021 | ||
| LU | 26.06.2021 | ||
| BE | 30.06.2021 | ||
| CH | 30.06.2021 | ||
| LI | 30.06.2021 | ||
| Frühere [2023/33] | HU | 26.06.2015 | |
| AL | 17.02.2021 | ||
| AT | 17.02.2021 | ||
| CY | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| IE | 26.06.2021 | ||
| LU | 26.06.2021 | ||
| BE | 30.06.2021 | ||
| CH | 30.06.2021 | ||
| LI | 30.06.2021 | ||
| Frühere [2023/30] | HU | 26.06.2015 | |
| AL | 17.02.2021 | ||
| AT | 17.02.2021 | ||
| CY | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| IE | 26.06.2021 | ||
| LU | 26.06.2021 | ||
| BE | 30.06.2021 | ||
| CH | 30.06.2021 | ||
| LI | 30.06.2021 | ||
| Frühere [2023/29] | HU | 26.06.2015 | |
| AL | 17.02.2021 | ||
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| IE | 26.06.2021 | ||
| LU | 26.06.2021 | ||
| BE | 30.06.2021 | ||
| CH | 30.06.2021 | ||
| LI | 30.06.2021 | ||
| Frühere [2022/34] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| IE | 26.06.2021 | ||
| LU | 26.06.2021 | ||
| BE | 30.06.2021 | ||
| CH | 30.06.2021 | ||
| LI | 30.06.2021 | ||
| Frühere [2022/23] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| IE | 26.06.2021 | ||
| LU | 26.06.2021 | ||
| CH | 30.06.2021 | ||
| LI | 30.06.2021 | ||
| Frühere [2022/21] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| IE | 26.06.2021 | ||
| LU | 26.06.2021 | ||
| CH | 30.06.2021 | ||
| LI | 30.06.2021 | ||
| Frühere [2022/18] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| LU | 26.06.2021 | ||
| Frühere [2022/13] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2022/10] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2022/07] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/51] | AT | 17.02.2021 | |
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/50] | AT | 17.02.2021 | |
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/49] | AT | 17.02.2021 | |
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/48] | AT | 17.02.2021 | |
| CZ | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/46] | AT | 17.02.2021 | |
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/42] | FI | 17.02.2021 | |
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/39] | FI | 17.02.2021 | |
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| PL | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/38] | FI | 17.02.2021 | |
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/37] | FI | 17.02.2021 | |
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/36] | FI | 17.02.2021 | |
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/35] | FI | 17.02.2021 | |
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| NO | 17.05.2021 | ||
| PT | 17.06.2021 | ||
| Frühere [2021/33] | FI | 17.02.2021 | |
| LT | 17.02.2021 | ||
| NO | 17.05.2021 | ||
| PT | 17.06.2021 | Angeführte Dokumente: | Recherche | [XY]WO2004031350 (AMGEN INC [US], et al) [X] 1,2,4-8 * the whole document * [Y] 1-15; | [E]EP2963108 (UNIV GENEVE [CH]) [E] 1-15 * the whole document *; | [XP] - RYOTARO BOUCHI ET AL, "FOXO1 inhibition yields functional insulin-producing cells in human gut organoid cultures", NATURE COMMUNICATIONS, (20140630), vol. 5, doi:10.1038/ncomms5242, XP055426778 [XP] 1-15 * the whole document * DOI: http://dx.doi.org/10.1038/ncomms5242 | [XDYI] - CHUTIMA TALCHAI ET AL, "Generation of functional insulin-producing cells in the gut by Foxo1 ablation", NATURE GENETICS, (20120101), vol. 44, no. 4, doi:10.1038/ng.2215, ISSN 1061-4036, pages 406 - 412, XP055145152 [XD] 1,4-9 * the whole document * * page 411, column r, paragraph 2 * [Y] 1-15 [I] 1-7,10 DOI: http://dx.doi.org/10.1038/ng.2215 | [XY] - V. T. SAMUEL ET AL, "Targeting Foxo1 in Mice Using Antisense Oligonucleotide Improves Hepatic and Peripheral Insulin Action", DIABETES, (20060701), vol. 55, no. 7, doi:10.2337/db05-0705, ISSN 0012-1797, pages 2042 - 2050, XP055095093 [X] 1,2,4-9 * abstract * * the whole document * [Y] 1-15 DOI: http://dx.doi.org/10.2337/db05-0705 | [XY] - T. NAGASHIMA ET AL, "Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice", MOLECULAR PHARMACOLOGY, (20100824), vol. 78, no. 5, doi:10.1124/mol.110.065714, ISSN 0026-895X, pages 961 - 970, XP055161324 [X] 1,4-8 * the whole document * [Y] 1-15 DOI: http://dx.doi.org/10.1124/mol.110.065714 | [XY] - TANAKA H ET AL, "Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER SCIENCE, NL, vol. 645, no. 1-3, ISSN 0014-2999, (20101025), pages 185 - 191, (20100723), XP027247568 [X] 1,4-8 * the whole document * [Y] 1-15 | [XY] - Y. BEHL ET AL, "FOXO1 Plays an Important Role in Enhanced Microvascular Cell Apoptosis and Microvascular Cell Loss in Type 1 and Type 2 Diabetic Rats", DIABETES, (20090123), vol. 58, no. 4, doi:10.2337/db08-0537, ISSN 0012-1797, pages 917 - 925, XP055144674 [X] 1,2,4-8 * the whole document * [Y] 1-15 DOI: http://dx.doi.org/10.2337/db08-0537 | Internationale Recherche | [A]WO2004009630 (BAYER HEALTHCARE AG [DE], et al) [A] 1-42 * ; page 9 lines 13-14; page 10, lines 1-2 *; | [XY]WO2011143511 (UNIV COLUMBIA [US], et al) [X] 43-63 * ; paragraphs [0030]-[0032], [0034], [0035], [0037], [0044], [0045], [0055], [0057], [0061], [0064], [0072], [0147] * [Y] 64-66, 70; | [Y] - GEISBAUER, CL et al., "Transplantation Of Enteric Cells Into The Rodent Stomach With Basic Fibroblast Growth Factor.", J Cell Sci Ther., (20110000), vol. 2, no. 1, XP055246820 [Y] 64-66 * ; DOI: 10.4172/2157-7013.1000103. abstract, page 5, paragraph 4. * DOI: http://dx.doi.org/10.4172/2157-7013.1000103 | [Y] - SATO, T et al., "Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium.", Gastroenterology., (20111100), vol. 141, no. 5, ISSN 0016-5085, pages 1762 - 1772, XP028325676 [Y] 70 * . DOI:10.1053/j.gastro.2011.07.050. page 1762, paragraphs 1, 3. * DOI: http://dx.doi.org/10.1053/j.gastro.2011.07.050 | [A] - PAULMANN, N et al., "Intracellular Serotonin Modulates Insulin Secretion From Pancreatic Beta-Cells By Protein Serotonylation.", PLoS Biol., (20091000), vol. 7, no. 10, XP055246822 [A] 1-42 * . DOI: 10.1371/journal.pbio.1000229. page 2, Author Summary. * DOI: http://dx.doi.org/10.1371/journal.pbio.1000229 | vom Anmelder | US4426330 | WO8502092 | US4522811 | US4534899 | US4946778 | US4987071 | US5013830 | US5013556 | US5108921 | US5116742 | US5149797 | US5213804 | US5220007 | US5227170 | US5256775 | US5264221 | US5354844 | US5356633 | US5366878 | US5395619 | US5403711 | US5416016 | US5417978 | US5459127 | US5462854 | US5469854 | US5491133 | US5512295 | US5521291 | US5527528 | US5534259 | US5543158 | US5543152 | US5547932 | US5556948 | US5565350 | US5580575 | US5583020 | US5591721 | US5595756 | US5623065 | US5652355 | US5652356 | US5700922 | US5877293 | US5886152 | US6054297 | US6355276 | US6560471 | US2004023390 | US7421943 | US7431943 | US7563884 | US7807649 | US2011041857 | US8470885 | US2013216554 | - R. DUMITRASCU et al., Eur Respir J, (20110000), vol. 37, pages 1104 - 1118 | - XIANG, S. et al., "In vitro and in vivo gene silencing by TransKingdom RNAi (tkRNAi", Methods Mol Biol, (20090000), vol. 487, pages 147 - 160 | - KRUHN, A. et al., "Delivery of short hairpin RNAs by transkingdom RNA interference modulates the classical ABCB1-mediated multidrug-resistant phenotype of cancer cells", Cell Cycle, (20090000), vol. 8 | - GAULTIER et al., Nucleic Acids. Res., (19870000), vol. 15, pages 6625 - 6641 | - INOUE et al., Nucleic Acids Res., (19870000), vol. 15, pages 6131 - 6148 | - INOUE et al., FEBS Lett., (19870000), vol. 215, pages 327 - 330 | - HASELHOFFGERLACH, Nature, (19880000), vol. 334, pages 585 - 591 | - BARTELSZOSTAK, Science, (19930000), vol. 261, pages 1411 - 1418 | - ROPELLE et al., Journal of Physiology, (20090000), vol. 587, pages 2341 - 2351 | - SAMUEL et al., Diabetes, (20060700), vol. 55, no. 7, pages 2042 - 50 | - DALY et al., Genes & Dev., (20040000), vol. 18, pages 1060 - 1071 | - BEHL et al., Diabetes, (20090400), vol. 58, no. 4, pages 917 - 25 | - POTENTE et al., J Clin Invest., (20050000), vol. 115, no. 9, pages 2382 - 2392 | - GOTO et al., British Journal of Cancer, (20080000), vol. 98, pages 1068 - 1075 | - ALIKANI et al., The Journal of Biological Chemistry, (20050000), vol. 280, pages 12096 - 12102 | - SIQUEIRA et al., Bone, (20110501), vol. 48, no. 5, pages 1043 - 1051 | - SAMARIN et al., The Journal of Biological Chemistry, (20100212), vol. 285, pages 4328 - 4336 | - TANAKA et al., Journal of Investigative Dermatology Symposium Proceedings, (20090000), vol. 14, pages 60 - 62 | - HRIBAL, J Cell Biol., (20030818), vol. 162, no. 4, pages 535 - 541 | - "Genbank", Database accession no. AI675189 | - "GenBank", Database accession no. M88070 | - HUSE et al., Science, (19890000), vol. 246, pages 1275 - 1281 | - BOWIE et al., Science, (19910000), vol. 253, page 164 | - TRASINO SE et al., Exp Biol Med (Maywood, (20070600), vol. 232, no. 6, pages 762 - 71 | - GRATTON et al., Nature Medicine, (20030000), vol. 9, pages 357 - 362 | - GRADWOHL, G.DIERICH, A.LEMEUR, M.GUILLEMOT, F., "neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas", Proc Natl Acad Sci USA, (20000000), vol. 97, doi:10.1073/pnas.97.4.1607, pages 1607 - 1611, XP002198929 DOI: http://dx.doi.org/10.1073/pnas.97.4.1607 | - MATSUMOTO et al., The Journal of Clinical Investigation, (20060900), vol. 116, no. 9 | - LIU et al., Cancer Gene Therapy, (20071200), vol. 14, pages 945 - 952 | - LABIED, S et al., Molecular Endocrinology, vol. 20, no. l, pages 35 - 44 | - S. STEPHEN et al., Cancer Research, (20100101), vol. 70, page 367 | - SHANER NSTEINBACH PTSIEN R, "A guide to choosing fluorescent proteins", Nat Methods, (20050000), vol. 2, no. 12, doi:10.1038/nmeth819, pages 905 - 9, XP055390890 DOI: http://dx.doi.org/10.1038/nmeth819 | - SCHULZ, T.C. et al., "A scalable system for production of functional pancreatic progenitors from human embryonic stem cells", PLoS One, (20120000), vol. 7, doi:10.1371/journal.pone.0037004, page e37004, XP055059403 DOI: http://dx.doi.org/10.1371/journal.pone.0037004 | - BLUM, B. et al., "Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3", Nature biotechnology, (20120000), vol. 30, doi:10.1038/nbt.2141, pages 261 - 264, XP009166388 DOI: http://dx.doi.org/10.1038/nbt.2141 | - HUA, H. et al., "iPSC-derived beta cells model diabetes due to glucokinase deficiency", J Clin Invest, (20130000), vol. 123, pages 3146 - 3153 | - MAEHR, R. et al., "Generation of pluripotent stem cells from patients with type 1 diabetes", Proc Natl Acad Sci USA, (20090000), vol. 106, doi:10.1073/PNAS.0906894106, pages 15768 - 15773, XP002633665 DOI: http://dx.doi.org/10.1073/PNAS.0906894106 | - SCHONHOFF, S.E.GIEL-MOLONEY, M.LEITER, A.B., "Minireview: Development and differentiation of gut endocrine cells", Endocrinology, (20040000), vol. 145, doi:10.1210/en.2004-0051, pages 2639 - 2644, XP002459635 DOI: http://dx.doi.org/10.1210/en.2004-0051 | - TALCHAI, C.XUAN, S.KITAMURA, T.DEPINHO, R.A.ACCILI, D., "Generation of functional insulin-producing cells in the gut by Foxol ablation", Nat Genet, (20120000), vol. 44, doi:10.1038/ng.2215, pages 406 - 412, XP055145152 DOI: http://dx.doi.org/10.1038/ng.2215 | - HABIB, A.M. et al., "Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry", Endocrinology, (20120000), vol. 153, pages 3054 - 3065 | - TALCHAI, C.XUAN, S.LIN, H.V.SUSSEL, L.ACCILI, D., "Pancreatic beta Cell Dedifferentiation as a Mechanism of Diabetic beta Cell Failure", Cell, (20120000), vol. 150, pages 1223 - 1234 | - THOREL, F. et al., "Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss", Nature, (20100000), vol. 464, pages 1149 - 1154 | - XU, X. et al., "Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas", Cell, (20080000), vol. 132, pages 197 - 207, XP002476713 | - ACCILI, D.ARDEN, K.C., "FoxOs at the crossroads of cellular metabolism, differentiation, and transformation", Cell, (20040000), vol. 117, doi:10.1016/S0092-8674(04)00452-0, pages 421 - 426, XP003014307 DOI: http://dx.doi.org/10.1016/S0092-8674(04)00452-0 | - SPENCE, J.R. et al., "Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro", Nature, (20110000), vol. 470, pages 105 - 109 | - VAN DER FLIER, L.G.HAEGEBARTH, A.STANGE, D.E.VAN DE WETERING, M.CLEVERS, H., "OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells", Gastroenterology, (20090000), vol. 137, doi:10.1053/j.gastro.2009.05.035, pages 15 - 17, XP026234025 DOI: http://dx.doi.org/10.1053/j.gastro.2009.05.035 | - VILLASENOR, A. et al., "EphB3 marks delaminating endocrine progenitor cells in the developing pancreas", Dev Dyn, (20120000), vol. 241, pages 1008 - 1019 | - SCOVILLE, D.H.SATO, T.HE, X.C.LI, L., "Current view: intestinal stem cells and signaling", Gastroenterology, (20080000), vol. 134, doi:10.1053/j.gastro.2008.01.079, pages 849 - 864, XP022516878 DOI: http://dx.doi.org/10.1053/j.gastro.2008.01.079 | - SCHWITZGEBEL, V.M. et al., "Expression of neurogenin3 reveals an islet cell precursor population in the pancreas", Development, (20000000), vol. 127, pages 3533 - 3542, XP002906536 | - LEE, C.S.PERREAULT, N.BRESTELLI, J.E.KAESTNER, K.H., "Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastriepithelial cell identity", Genes Dev, (20020000), vol. 16, pages 1488 - 1497 | - OHTA, Y. et al., "Convergence of the insulin and serotonin programs in the pancreatic beta-cell", Diabetes, (20110000), vol. 60, pages 3208 - 3216 | - GAGNON, J.MAYNE, J.MBIKAY, M.WOULFE, J.CHRETIEN, M., "Expression of PCSK1 (PC 1/3), PCSK2 (PC2) and PCSK3 (furin) in mouse small intestine", Regulatory peptides, (20090000), vol. 152, doi:10.1016/j.regpep.2008.07.006, pages 54 - 60, XP025780814 DOI: http://dx.doi.org/10.1016/j.regpep.2008.07.006 | - FUJITA, Y.ASADI, A.YANG, G.K.KWOK, Y.N.KIEFFER, T.J., "Differential processing of proglucose-dependent insulinotropic polypeptide in gut", American journal of physiology. Gastrointestinal and liver physiology, (20100000), vol. 298, pages G608 - 614 | - NIELSEN, L.B. et al., "Co-localisation of the Kir6.2/SUR1 channel complex with glucagonlike peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes", Eur J Endocrinol, (20070000), vol. 156, pages 663 - 671 | - MCCRACKEN, K.W.HOWELL, J.C.WELLS, J.M.SPENCE, J.R., "Generating human intestinal tissue from pluripotent stem cells in vitro", Nature protocols, (20110000), vol. 6, doi:10.1038/nprot.2011.410, pages 1920 - 1928, XP055210541 DOI: http://dx.doi.org/10.1038/nprot.2011.410 | - NAKAE, J.KITAMURA, T.SILVER, D.L.ACCILI, D., "The forkhead transcription factor Foxol (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression", The Journal of clinical investigation, (20010000), vol. 108, pages 1359 - 1367 | - KITAMURA, T. et al., "A Foxo/Notch pathway controls myogenic differentiation and fiber type specification", The Journal of clinical investigation, (20070000), vol. 117, pages 2477 - 2485 | - CHEUNG, A.T. et al., "Glucose-dependent insulin release from genetically engineered K cells", Science, (20000000), vol. 290, doi:10.1126/science.290.5498.1959, pages 1959 - 1962, XP002359298 DOI: http://dx.doi.org/10.1126/science.290.5498.1959 | - OHARA-IMAIZUMI, M. et al., "Serotonin regulates glucose-stimulated insulin secretion from pancreatic beta cells during pregnancy", Proc Natl Acad Sci US A, (20130000), vol. 110, pages 19420 - 19425 | - CHEN, Y.J. et al., "De Novo Formation of Insulin-Producing ''Neo-beta Cell Islets'' from Intestinal Crypts", Cell reports, (20140000), vol. 6, pages 1046 - 1058 | - PAJVANI, U.B. et al., "Inhibition of Notch signaling ameliorates insulin resistance in a FoxOl-dependent manner", Nature medicine, (20110000), vol. 17, pages 961 - 967 | - KITAMURA, T. et al., "The forkhead transcription factor Foxol links insulin signaling to Pdxl regulation of pancreatic beta cell growth", The Journal of clinical investigation, (20020000), vol. 110, pages 1839 - 1847 | - TANAKA, H. et al., "Effects of the novel Foxol inhibitor AS 1708727 on plasma glucose and triglyceride levels in diabetic db/db mice", Eur J Pharmacol, (20100000), vol. 645, pages 185 - 191, XP027247568 |